Israel's Teva Pharmaceutical Industries said it would buy U.S. neurology drug company Auspex Pharmaceuticals Inc for an equity value of $3.5 billion to boost its portfolio of treatments for the central nervous system.
Tags: Goldman Sachs
CVC and Temasek to buy $2 billion generic drugs firm Alvogen
European private equity fund CVC and Singaporean sovereign wealth fund Temasek [TEM.UL] are to buy a controlling stake in the pharmaceutical firm Alvogen, its chairman and chief executive said.
Fed keeps lid on dollar, yields; Greece hurts stocks
Bond yields and the dollar fell on Thursday after the Federal Reserve signaled that U.S. interest rates would rise more slowly than markets had expected, while Greece's drift closer to default pushed European stocks lower.
CVS Health to buy Target's pharmacy business for $1.9 billion
Drugstore operator CVS Health Corp (CVS.N) will buy Target Corp's (TGT.N) pharmacies and clinics in a $1.9 billion deal that should help it bargain with drug makers for lower prices, while freeing Target from a costly business where it struggled to make a profit.
Oil prices rise on U.S. stock draw, strong Japan data
Crude oil prices bounced back on Wednesday from steep falls in the previous session as industry data showed that U.S. crude stocks fell more than expected last week.
Latest News
Goldman Sachs became the top commodities bank last year, overtaking rival JP Morgan, a consultancy said on Friday.
Deutsche Bank's (DBKGn.DE) retail operations will bear the brunt of its planned restructuring and will most likely be spun off in a stock market listing, two sources familiar with internal discussions at Germany's biggest bank said on Saturday.
German stocks surged to a record high on Monday as investors shrugged off a bounce by the euro and focussed on the expected boost to corporate earnings from the currency's recent slump, which saw it touch a 12-year low earlier in the day.
Bankers running the expected A$3 billion ($2.29 billion) initial public offering of Australian software firm MYOB Ltd, owned by Bain Capital, plan to file a prospectus for the sale by end-March, two people familiar with the matter told Reuters.
For a world economy coming to terms with a soaring dollar and a plunge in oil prices, this week will be all about the U.S. Federal Reserve's policy meeting and its intentions on interest rates.
Credit Suisse (CSGN.VX) is bringing in Tidjane Thiam, the head of British insurer Prudential (PRU.L), as its new chief executive to help drive the Swiss bank's push into wealth management in emerging markets.
Many of Wall Street's biggest banks are more convinced the Federal Reserve will raise interest rates in June after a strong February jobs report on Friday pointed to sustained economic growth and as the jobless rate hit a more than 6-1/2 year-low.
Oil prices fell on Monday as worries about oversupply in North America and a strong dollar pushed Brent futures towards $59 a barrel and U.S. contracts below $49 a barrel.
General Motors Co (GM.N) has turned to two investment banks to help it come up with a response to a shareholder group demanding $8 billion in stock buybacks and a seat on the board of the No. 1 U.S. automaker, the company told Reuters.
